(Q54550124)

31 May 2018

title

Captopril and frusemide in severe drug-resistant hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6105292

6 August 2023

main subject

arterial hypertension

0 references

1 reference

1

N J White

1 reference

31 May 2018

B. Rajagopalan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6105292

6 August 2023

H. Yahaya

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6105292

6 August 2023

J. G. Ledingham

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6105292

6 August 2023

language of work or name

English

0 references

publication date

1 July 1980

1 reference

31 May 2018

19 July 1980

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6105292

6 August 2023

number of pages

3

1 reference

full work available at URL

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0140673680900021?httpAccept=text/xml

1 reference

10.1016/S0140-6736(80)90002-1

DOI

https://api.crossref.org/works/10.1016/S0140-6736(80)90002-1

https://api.elsevier.com/content/article/PII:S0140673680900021?httpAccept=text/plain

6 August 2023

1 reference

10.1016/S0140-6736(80)90002-1

DOI

https://api.crossref.org/works/10.1016/S0140-6736(80)90002-1

6 August 2023

1 reference

31 May 2018

volume

2

1 reference

31 May 2018

issue

8186

1 reference

31 May 2018

page(s)

108-110

1 reference

31 May 2018

CAPTOPRIL IN THE TREATMENT OF CLINICAL HYPERTENSION AND CARDIAC FAILURE

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2990002-1

7 January 2021

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2990002-1

7 January 2021

Response of Arterial Blood Pressure, Plasma Renin Activity and Plasma Aldosterone Concentration to Long-Term Administration of Captopril in Patients with Severe, Treatment-Resistant Malignant Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2990002-1

7 January 2021

Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2990002-1

7 January 2021

Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2990002-1

7 January 2021

Minoxidil in resistant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2990002-1

7 January 2021

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2990002-1

7 January 2021

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2990002-1

7 January 2021

10.1016/S0140-6736(80)90002-1

Identifiers

DOI

1 reference

31 May 2018

1 reference

31 May 2018